Costs of Development. 25 3.6 Joint Development and Marketing Activities..............................25 3.7 Compliance with Law and Safety and Adverse Event Reporting..............26 3.8
Appears in 2 contracts
Sources: Exclusive Sublicense Agreement (Intermune Pharmaceuticals Inc), Exclusive Sublicense Agreement (Intermune Pharmaceuticals Inc)